SwePub
Sök i LIBRIS databas

  Extended search

(WFRF:(Karling Pontus)) srt2:(2015-2019)
 

Search: (WFRF:(Karling Pontus)) srt2:(2015-2019) > The Combined Value ...

The Combined Value of Faecal Haemoglobin andCalprotectin in Diagnosis of Colorectal Cancer inSymptomatic Patients Referred to Colonoscopy

Eklöf, Vincy, 1984- (author)
Umeå universitet,Patologi
Lundgren, David (author)
Umeå universitet,Institutionen för folkhälsa och klinisk medicin
Karling, Pontus (author)
Umeå universitet,Institutionen för folkhälsa och klinisk medicin
show more...
Wikberg, Maria L. (author)
Umeå universitet,Patologi
Edin, Sofia (author)
Umeå universitet,Patologi
Löfgren Burström, Anna (author)
Umeå universitet,Patologi
Rutegård, Jörgen, 1948- (author)
Umeå universitet,Kirurgi
Palmqvist, Richard (author)
Umeå universitet,Patologi
show less...
 (creator_code:org_t)
San Fransisco : Iris Publishers, 2019
2019
English.
In: Academic Journal of Gastroenterology & Hepatology (AJGH). - San Fransisco : Iris Publishers. ; 1:3, s. 1-7
  • Journal article (other academic/artistic)
Abstract Subject headings
Close  
  • Aim: To investigate the diagnostic value of a combined analyses of faecal immunological haemoglobin (FIT) and faecal calprotectin (FC) in detection of colorectal cancer (CRC).Methods: Out-patients (n=1440) referred to the endoscopy unit were analysed for FIT and FC in stool samples collected before the colonoscopy bowel preparation. The samples were collected from one defecation by the patients at home. Patients with IBD were excluded leaving stool samples from 1133 patients for further analyses. FIT was analysed using the immunological Analyse F.O.B Test and FC was analysed using the CALPRO® Calprotectin Elisa Test. Sensitivity and specificity to detect CRC was calculated for the individual tests, as well as for combined FIT/FC tests.Results: Out of the included patients, 38 were diagnosed with CRC, 9 with high grade dysplasia (HGD), and 133 with low grade dysplasia (LGD). FIT was analysed in 673 (59.4%), FC in 1021 (90.1%) and both FIT and FC in 561 (49.5%) patients. A ROC curve analysis showed that the most accurate cut-off level for FC in detecting CRC in our study was 105.5 µg/g. The sensitivity for CRC when using FIT, FC (cut-off > 100 µg/g) and the combination of FIT and FC (at least one positive test) was 65.5%, 74.1% and 94.4%, respectively. The corresponding specificity was 84.8%, 74.9% and 68.3%, respectively.Conclusion: Combined analyses of FIT and FC improved sensitivity for detection of CRC. Further studies in larger cohorts are required to find the optimal cut-off levels for different combinations of tests.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Keyword

Colorectal cancer; F-Calprotectin; F-Hb: Faecal markers; Screening markers

Publication and Content Type

vet (subject category)
art (subject category)

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view